Tenascin-C targeting strategies in cancer

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Tenascin-C (TNC) is a matricellular glycoprotein upregulated in pathological conditions like cancer and chronic inflammation.
• TNC has long been recognized as a potential diagnostic and therapeutic target in oncology, with numerous clinical trials conducted.
• Its role extends beyond structural support to influencing immune responses.

Purpose of the Study:

• To review advanced strategies for Tenascin-C (TNC) detection.
• To provide an overview of current anti-TNC theranostic approaches and clinical strategies.
• To discuss novel treatment protocols focusing on the immune-modulating functions of TNC.

Main Methods:

• Literature review of advanced detection techniques for TNC.
• Analysis of current theranostic strategies targeting TNC in cancer.
• Exploration of emerging treatment protocols involving TNC's immunomodulatory roles.

Main Results:

• TNC is a significant biomarker and therapeutic target in various cancers and inflammatory diseases.
• Advanced detection methods and theranostic approaches for TNC are under active clinical investigation.
• Targeting TNC's immune-modulating functions presents a promising avenue for novel cancer therapies.

Conclusions:

• Tenascin-C (TNC) remains a critical target for cancer diagnostics and therapeutics.
• Current research focuses on sophisticated theranostic tools and immune-centric treatment strategies involving TNC.
• Future directions emphasize harnessing TNC's immunomodulatory properties for enhanced anti-cancer efficacy.